Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
3.400
-0.270 (-7.36%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $322.59 million as of June 5, 2026. Its market cap has increased by 406.18% in one year.
Market Cap
322.59M
Enterprise Value
97.00M
1-Year Change
406.18%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $322.59M, an increase of 92.80%. That is a compound annual growth rate of 14.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 322.59M | -5.32% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 340.12M |
| Artiva Biotherapeutics | 332.83M |
| Larimar Therapeutics | 330.89M |
| Enanta Pharmaceuticals | 328.00M |
| Greenwich LifeSciences | 326.59M |
| Verastem | 326.01M |
| REGENXBIO | 314.32M |
| Abeona Therapeutics | 311.48M |